(Total Views: 442)
Posted On: 03/02/2020 8:36:35 AM
Post# of 152324
Why are you posting this everywhere when the PR clearly states:
Quote:
CytoDyn plans to seek FDA approval for leronlimab in combination therapy and plans to complete the filing of a Biologics License Application (BLA) in the first quarter of 2020 for that indication.
(2)
(0)Scroll down for more posts ▼
